Related Experiment Videos

On the significance of C2, C4, and factor B polymorphisms in disease

Human Genetics
|January 1, 1981
PubMed

Insights

Rare complement gene variants (C2, C4, Factor B) are linked to diseases like diabetes and multiple sclerosis, potentially causing functional deficiencies and impacting immune responses.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Human Genetics

Background:

  • Diseases such as insulin-dependent diabetes mellitus, multiple sclerosis, and idiopathic membranous nephropathy are strongly associated with HLA-DR alleles.
  • Emerging evidence suggests a connection between these conditions and rare alleles of complement system genes: C2, C4, and Factor B.

Purpose of the Study:

  • To review recent evidence linking rare complement gene variants to specific autoimmune and infectious diseases.
  • To explore the potential functional consequences of these rare variants on immune effector mechanisms.

Main Methods:

  • Review of existing scientific literature and evidence.
  • Analysis of genetic associations between complement alleles and disease phenotypes.
  • Hypothesizing functional mechanisms based on known gene interactions.

Main Results:

  • Rare C2, C4, and Factor B alleles are associated with HLA-DR-linked diseases.
  • Circumstantial evidence suggests these rare variants may be functionally deficient.
  • Impaired complement function could affect viral lysis, neutralization, and vascular permeability.

Conclusions:

  • Mutant complement genes may impair immune effector functions, contributing to disease pathogenesis.
  • Alterations in complement pathways could play a role in conditions like proliferative retinopathy and familial hypertension.
  • Functionally deficient complement alleles, such as C4F1, may be implicated in diseases like lepromatous leprosy.

Related Concept Videos